Correlation Between SAB Biotherapeutics and AstraZeneca PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and AstraZeneca PLC ADR, you can compare the effects of market volatilities on SAB Biotherapeutics and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and AstraZeneca PLC.

Diversification Opportunities for SAB Biotherapeutics and AstraZeneca PLC

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between SAB and AstraZeneca is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and AstraZeneca PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC ADR and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC ADR has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and AstraZeneca PLC

Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 11.28 times more return on investment than AstraZeneca PLC. However, SAB Biotherapeutics is 11.28 times more volatile than AstraZeneca PLC ADR. It trades about 0.18 of its potential returns per unit of risk. AstraZeneca PLC ADR is currently generating about -0.27 per unit of risk. If you would invest  5.01  in SAB Biotherapeutics on August 26, 2024 and sell it today you would earn a total of  2.29  from holding SAB Biotherapeutics or generate 45.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy86.36%
ValuesDaily Returns

SAB Biotherapeutics  vs.  AstraZeneca PLC ADR

 Performance 
       Timeline  
SAB Biotherapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, SAB Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
AstraZeneca PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AstraZeneca PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

SAB Biotherapeutics and AstraZeneca PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SAB Biotherapeutics and AstraZeneca PLC

The main advantage of trading using opposite SAB Biotherapeutics and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.
The idea behind SAB Biotherapeutics and AstraZeneca PLC ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges